EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Perspectives on the Treatment of Multiple Myeloma

Abdul Rafae, Frits van Rhee, Samer Al Hadidi iD

The Oncologist · 04.03.2024 · 29 (3) · 200-212

DOI: 10.1093/oncolo/oyad306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 23.11.2023. Verfasst von Abdul Rafae und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of multiple myeloma has evolved significantly over the past few decades with the development of novel therapeutics. The introduction of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and high-dose chemotherapy followed by hematopoietic stem cell transplantation has led to improved response rates and survival outcomes. The use of bispecific antibodies and chimeric antigen receptor T-cell therapy is currently under study, and early results are showing promise. Although outcomes for patients with MM have improved with the development of new treatments, there remains a subset of patients with high-risk disease who have a particularly poor prognosis. Therefore, it is critical that future clinical trials focus on developing new therapies specifically for high-risk multiple myeloma. Here we review the literature and provide guidance on treating patients with multiple myeloma for practicing oncologists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHematopoietic Stem Cell TransplantationHumansAntibodies, MonoclonalImmunotherapyImmunotherapy, Adoptive

Stichwörter der Autor:innen

multiple myelomatransplantationtreatment

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Myeloma Institute, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

ORCID-Profile: Samer Al Hadidi

Zitieren

APA

Rafae, A., van Rhee, F., & Al Hadidi, S. (2024). Perspectives on the Treatment of Multiple Myeloma. The Oncologist, 29(3), 200-212. https://doi.org/10.1093/oncolo/oyad306

Vancouver

Rafae A, van Rhee F, Al Hadidi S. Perspectives on the Treatment of Multiple Myeloma. The Oncologist. 2024;29(3):200-212. doi:10.1093/oncolo/oyad306

BibTeX
@article{Rafae2024,
  author = {Rafae, Abdul and van Rhee, Frits and Al Hadidi, Samer},
  title = {Perspectives on the Treatment of Multiple Myeloma},
  journal = {The Oncologist},
  year = {2024},
  volume = {29},
  number = {3},
  pages = {200--212},
  doi = {10.1093/oncolo/oyad306}
}
Kostenlos starten →